Development and validation of the NCC‐BC‐A scale to assess patient‐reported outcomes for breast cancer patients in China
The NCC-BC-A scale has high validity and reliability. It comprehensively considered the characteristics of systemic treatment for breast cancer, and the specific context within China. Its implementation may help clinicians to pay more attention to quality of life of breast cancer patients and to optimize the system for managing this condition.
Authors
- Fei Ma (ORCID: https://orcid.org/0000-0001-9432-1902)
- Xiuwen Guan (ORCID: https://orcid.org/0000-0003-1796-8993)
- Xiaoyan Yan (ORCID: https://orcid.org/0000-0001-6651-9372)
- Tianmou Liu
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
Publication Details
- Journal
- Cancer Innovation
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1002/cai2.141
- Citations
- 3
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- Anhui Medical University
- Government of Jiangsu Province
- Fudan University
- Huazhong University of Science and Technology
- Tongji University
- Chinese Academy of Medical Sciences
- Peking University
- Tianjin Medical University
- Peking Union Medical College
- Dalian Medical University
- Shandong First Medical University
- Shandong Academy of Medical Sciences